Non-commuting intentions during COVID-19 in Nanjing, China: A hybrid latent class modeling approach.

Non-commuting travel is essential for people to meet daily demands and regulate mental health, which is greatly disrupted due to the COVID-19 pandemic. To explore non-commuting intentions during COVID-19 across different groups of residents, this paper uses online survey data in Nanjing and constructs a hybrid latent class choice model that combines sociodemographic characteristics and psychological factors. Results showed that the respondents can be divided into two groups: the "cautious" group versus the "fearless" group. The "cautious" group with lower willingness to travel tend to be older, higher-income, higher-educated, female and full-time employees. Furthermore, the "cautious" group with higher perceived susceptibility is more obedient to government policies. In contrast, the "fearless" group is significantly affected by perceived severity and is more inclined to turn to personal protection against the pandemic. These results suggested that non-commuting trips were influenced not only by individual characteristics but also by psychological factors. Finally, the paper provides implications for the government to formulate COVID-19 management measures for the heterogeneity of different groups.

Virus transmission risk of college students in railway station during Post-COVID-19 era: Combining the social force model and the virus transmission model.

In the post-epidemic era, people's lives are gradually returning to normal, and travel is gradually resuming. The safe evacuation of cross-regional travelers in railway station has also attracted more and more attention, especially the evacuation behavior of college students in railway station. In this paper, considering the pedestrian dynamics mechanism in the emergency evacuation process during the COVID-19 normalized epidemic prevention and control, an Agent-based social force model was established to simulate the activities of college students in railway station. Combined with the virus infection transmission model, Monte Carlo simulation was used to calculate the total exposure time and the number of high-risk exposed people in the railway station evacuation process. In addition, sensitivity analysis was conducted on the total exposure time and the number of high-risk exposed people under 180 combinations of the number of initial infections, social distance, and the proportion of people wearing masks incorrectly. The results show that with the increase of social distances, the total exposure time and the number of high-risk exposures do not always decrease, but increase in some cases. The presence or absence of obstacles in the evacuation scene has no significant difference in the effects on total exposure time and the number of high-risk exposures. During the evacuation behavior of college students in railway station, choosing the appropriate number of lines can effectively reduce the total exposure time and the number of high-risk exposures. Finally, some policy suggestions are proposed to reduce the risk of virus transmission in the railway station evacuation process, such as choosing dynamic and reasonable social distance and the number of queues, and reducing obstacles.

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma.

Patients with relapsed/refractory early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) respond poorly to traditional therapy and have dismal prognosis. CD7 is a promising therapeutic targets for chimeric antigen receptor modified T cell therapy (CART) due to its widely expression in almost all T-cell malignancies. Here we present the anti-CD7 CART therapy in a 11-year-old male with TP53 mutated relapsed/refractory ETP-ALL/LBL. The patient suffered second relapse after haploidentical hematopoietic stem cell transplantation, showing resistance to 4 lines salvage therapies including venetoclax. Nanobody derived CD7-CART cells were manufactured by co-transducing CAR-T cells with a CD7 protein expression blocker. 70.5% of blasts (CD7 expression: 92.6%) and extensive extramedullary disease (mediastinal mass, enlarged lymph nodes and spleen) were observed prior to CD7-CART-cell therapy. A total of 5 × 106/kg donor-derived CD7-CART-cells were infused. Hematological and extramedullary remission were both achieved, with persistence of CD7-CART-cells be detected until the last followup at 96th days after the infusion. Reversible adverse effects including grade 3 cytokine release syndrome and macrophage activation syndrome were observed. This case demonstrated that CD7-CART was a potent and safe salvage therapy in relapsed/refractory ETP-ALL/LBL patient with high tumor burden.Trial registration: ClinicalTrials. gov, NCT04785833 , Registered on March 8, 2021, prospectively registered.